Thomas Bachmann is New Chief Executive Officer of the Eppendorf Group
News Aug 04, 2015
Following the departure of Eppendorf's previous CEO, the company's Chief Financial Officer, Detmar Ammermann, had exercised the function of Spokesman of the Management Board on an interim basis in addition to his responsibilities as CFO.
Bachmann, who has been a member of the Eppendorf Supervisory Board since 2013, came to Eppendorf from his position as President of the Bruker BioSpin Group. He has been active in the life science sector since 2005, when he took on the overall management of the globally active Tecan Group, which is headquartered in Switzerland.
"We are very pleased that we have been able to win Thomas Bachmann as our Chief Executive Officer," said Klaus Fink, Chairman of the Supervisory Board of the Eppendorf Group. "He has demonstrated his expertise and his strategic foresight in many ways during more than 25 years of experience in international management positions."
Bachmann explains: "Eppendorf is an innovative, customer-oriented company with a strong, well-known brand and a global orientation, and it succeeds again and again in making important contributions to analytic, medical, diagnostic and life science laboratories. I am looking forward to working with Eppendorf's very competent and committed global management to develop the company sustainably and successfully in the years to come."
New Software Allows Mobile Monitoring of Breathing ProblemsNews
Researchers have developed new software that makes it possible to use low-cost, thermal cameras attached to mobile phones to track how fast a person is breathing.READ MORE
Agilent Announces Expanded Use of Cancer Diagnostic in the USNews
Agilent announced that the FDA has approved the cancer diagnostic known as PD-L1 IHC 28-8 pharmDx for use in cases of urothelial carcinoma (UC) and of squamous cell carcinoma of the head and neck (SCCHN).READ MORE
Blood Test for Colitis Screening Could Reduce Dependence on ColonoscopyNews
A fast, simple blood test for ulcerative colitis using infrared spectroscopy could provide a cheaper, less invasive alternative for screening compared to colonoscopy, which is now the predominant test.READ MORE
Comments | 0 ADD COMMENT
13th Edition of International Conference on Pediatric Gastroenterology
Aug 02 - Aug 04, 2018